Mohammad A. Rafi
1*1 Department of Neurology, Jefferson Medical College, Philadelphia, Pennsylvanian 19107, USA
Abstract
Introduction:
Both gene and stem cell therapies hold great promise in the treatment
of many genetic diseases and are currently focus of interest for many
investigators. While both approaches are offering great and valuable
treatment options for devastating and life-threatening diseases, they
hold much greater promise in combination. Methods:
As there are multiple options in selecting gene transfer vehicles among
the non-viral and viral vectors, there are also many options among the
different transplantable cell types ranging from lineage-restricted
progenitor cells to multipotent and pluripotent stem cells. Here,
combination of the gene therapy and stem cell therapy is discussed. Results:
Several successful gene and stem cell therapies have been reported both
in animal and human trials. Combination of the gene therapy and stem
cell therapy can be carried out sequentially where the cell
transplantation and the in vivo gene therapy are accomplished one after the other; or, as it is more commonly practiced, they can be carried out as ex vivo gene therapy where the transplantable cells are genetically modified outside the body before being transplanted into the body. Conclusion:
The combination of the stem-cell technology with gene therapy has the
potential of providing both regenerative tissue and therapeutic material
simultaneously; therefore, having the benefits of both technologies.